Comparision of bixalomer (Kiklin) dose timing as phosphate binder and impact in HD patients
Not Applicable
- Conditions
- Hemodialysis patients with hyperphosphatemia
- Registration Number
- JPRN-UMIN000009792
- Lead Sponsor
- Juntendo University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
ients are excluded if they are compatible with any one of the following criteria. 1.Patients with a history of hypersensitivity for an ingredient of this medicine 2.Patients with bowel obstruction (for a non-absorbable polymer, we might raise intestinal perforation) 3.Patients with significant psychic disturbance or drug dependence disease or alcoholism 4.Patients that going to hospital of all follow-up seems to be impossible 5.Patients who are not able to understand a test instructions from medical experts of the client side or the doctors involved in the study 6.Patients who judged as inadequate by the doctors involved in the study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method evel of serum phosphate
- Secondary Outcome Measures
Name Time Method Evaluation of efficacy *Blood gas concentrations *Abdominal symptoms evaluation *Drug remedy time estimation *Adverse events